nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiproliferative Effects of Combined Tamoxifen and Gefitinib in Non-Small Cell Lung Cancer
|
Shen, Hua |
|
2009 |
63 |
5 |
p. 327- 1 p. |
artikel |
2 |
Association between MicroRNA Polymorphisms, Expressions, Lung Cancer Development and Prognosis
|
Hu, Zhibin |
|
2009 |
63 |
5 |
p. 322- 1 p. |
artikel |
3 |
BRCA1 and β-tubulin III mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to docetaxel
|
Liu, Baorui |
|
2009 |
63 |
5 |
p. 321- 1 p. |
artikel |
4 |
Cancer Genetic Signatures
|
HT DUC, |
|
2009 |
63 |
5 |
p. 327-328 2 p. |
artikel |
5 |
Cancer stem cells : the new target for fighting caner from the latest translational research
|
Ren, Jun |
|
2009 |
63 |
5 |
p. 326- 1 p. |
artikel |
6 |
Comparing the Diagnostic Value of FLT and FDG PET/CT in Assessment of Regional Lymph Nodes in Thoracic Esophageal Squamous Cell Carcinoma
|
Yu, Jinming |
|
2009 |
63 |
5 |
p. 322-323 2 p. |
artikel |
7 |
Editorial board
|
|
|
2009 |
63 |
5 |
p. IFC- 1 p. |
artikel |
8 |
Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene
|
Wang, Tong-shan |
|
2009 |
63 |
5 |
p. 326-327 2 p. |
artikel |
9 |
First-Line Single Agent Treatment With Gefitinib in Advanced Non–Small-Cell Lung Cancer Patients
|
Yin, Yong-mei |
|
2009 |
63 |
5 |
p. 325- 1 p. |
artikel |
10 |
Gene Expression Profile Towards the Prediction of Patient Survival of Gastric Cancer
|
Xu, Zhen-yu |
|
2009 |
63 |
5 |
p. 324- 1 p. |
artikel |
11 |
Gene Therapy in the 21st century: A progress report
|
Norris, Jim |
|
2009 |
63 |
5 |
p. 328- 1 p. |
artikel |
12 |
HER2-targeted Tumor immunotherapy
|
Huafeng Wei, |
|
2009 |
63 |
5 |
p. 325-326 2 p. |
artikel |
13 |
Increased nitric oxide release by neutrophils of a patient with tyrosinemia type III
|
D'Eufemia, Patrizia |
|
2009 |
63 |
5 |
p. 359-361 3 p. |
artikel |
14 |
Inhibition of inflammatory mediator secretion by (−)-DHMEQ in mouse bone marrow-derived macrophages
|
Suzuki, Eriko |
|
2009 |
63 |
5 |
p. 351-358 8 p. |
artikel |
15 |
Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2
|
Guo, Renhua |
|
2009 |
63 |
5 |
p. 324-325 2 p. |
artikel |
16 |
Irinotecan plus cisplatin for the treatment of small cell carcinoma
|
Jin, Shi-dai |
|
2009 |
63 |
5 |
p. 323-324 2 p. |
artikel |
17 |
New Kallikrein markers for ovarian cancers
|
Barak, V. |
|
2009 |
63 |
5 |
p. 329-330 2 p. |
artikel |
18 |
Pharmacology of A Mimetic of Oxidized Glutathione
|
Townsend, Danyelle M. |
|
2009 |
63 |
5 |
p. 328-329 2 p. |
artikel |
19 |
Plasma Protein Biomarkers as Indicators of Pharmacokinetics and Pharmacodynamics in the Development of Novel Cancer Drugs
|
Tew, Kenneth D. |
|
2009 |
63 |
5 |
p. 329- 1 p. |
artikel |
20 |
P38MAPK regulates caspase-3 by binding to caspase-3 in nucleus of human hepatoma Bel-7402 cells during anti-Fas antibody- and actinomycin D-induced apoptosis
|
Wang, Yu |
|
2009 |
63 |
5 |
p. 343-350 8 p. |
artikel |
21 |
Potential Efficacy of Multi-targeted Tyrosine Kinase Inhibitors in Non-small-cell Lung Cancer
|
Chen, Jinfei |
|
2009 |
63 |
5 |
p. 322- 1 p. |
artikel |
22 |
Predictive effects of RRM1, ERCC1, XRCC3, BRCA1 and EGFR genotyping or expression for clinical outcome of advanced NSCLC patients treated with cisplatin–based chemotherapy or gefitinib
|
Zhou, Caicun |
|
2009 |
63 |
5 |
p. 321-322 2 p. |
artikel |
23 |
Prognosis Significance of Cytokeratins-TPS, TPA compared to Tumor mass Markers in Breast Cancer
|
Barak, Vivian |
|
2009 |
63 |
5 |
p. 328- 1 p. |
artikel |
24 |
Relationship of XRCC1 and XPD genetic polymorphisms and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer
|
Huang, Xin-En |
|
2009 |
63 |
5 |
p. 323- 1 p. |
artikel |
25 |
Resistin and insulin resistance in hepatocytes: Resistin disturbs glycogen metabolism at the protein level
|
Yang, Yang |
|
2009 |
63 |
5 |
p. 366-374 9 p. |
artikel |
26 |
Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor ( βARKct ) gene transfer in a rat model of severe pressure overload
|
Molina, Ezequiel J. |
|
2009 |
63 |
5 |
p. 331-336 6 p. |
artikel |
27 |
Screening of immune function inhibitors with anticancer activity from microorganisms
|
Umezawa, Kazuo |
|
2009 |
63 |
5 |
p. 328- 1 p. |
artikel |
28 |
Screening of traditional Chinese medicine with antitumor effect and the isolation of effective chemical constituents from Forsythia suspense (Thunb) Vhal. (Oleaceae): studying the mechanism of its apoptotic-induction
|
Sun, Jin |
|
2009 |
63 |
5 |
p. 326- 1 p. |
artikel |
29 |
Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression
|
Guo, Renhua |
|
2009 |
63 |
5 |
p. 375-379 5 p. |
artikel |
30 |
The anti-tumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo
|
Long-bang, Chen |
|
2009 |
63 |
5 |
p. 323- 1 p. |
artikel |
31 |
The effect of HIFU combined with endostar and gemcitabine on the animal xenograft model of human pancreatic cancer
|
Rong-sheng, Wang |
|
2009 |
63 |
5 |
p. 325- 1 p. |
artikel |
32 |
The metabolic syndrome, an epidemic among HIV-infected patients on HAART
|
Jevtović, Dj. |
|
2009 |
63 |
5 |
p. 337-342 6 p. |
artikel |
33 |
The Synergistic Effects of Nedaplatin and Cispaltin on the Proliferation and Apoptosis of Human Ovarian Carcinoma Skov-3 and Cervical Carcinoma Hela Cell Line
|
Suyi, LI |
|
2009 |
63 |
5 |
p. 327- 1 p. |
artikel |
34 |
The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis
|
Actis, Giovanni C. |
|
2009 |
63 |
5 |
p. 362-365 4 p. |
artikel |
35 |
TIMP-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1
|
Wang, Ting |
|
2009 |
63 |
5 |
p. 324- 1 p. |
artikel |